Dítĕ P, Novotný I, Precechtĕlová M, Růzicka M, Záková A, Trna J, Hermannová M, Sevcíková A
Interní hepatogastroenterologická klinika Lékarské fakulty MU a FN Brno, pracovistĕ Bohunice.
Vnitr Lek. 2009 Jan;55(1):18-21.
Pancreatic carcinoma is one of the diseases which mostly fail to be diagnosed on a timely basis, and there is no way to effectively screen patients for pancreatic carcinoma either. An option for the diagnosis of the "early glandular carcinoma" therefore resides in identification and systematic screening of patients with risk of pancreatic carcinoma.
We monitored 223 patients with chronic pancreatitis on a systematic basis from 1992 to 2005. During this 14-year period, we monitored the number of cigarettes smoked per year in addition to standard parametres measured by biochemical methods, endosonography, CT and ERCP exams, and assigned the alcoholic form of chronic pancreatitis to patients consuming more than 80g of alcohol per day on a systematic basis for more than 5 years in the case of men, and 50 g of alcohol per day in the case of women, and classed the patients according the TIGARO classification.
Alcoholic etiology was proven in 73.1% of the examined patients, chronic obstructive form of pancreatitis was diagnosed in 21.5% of patients, and only 5.4% of patients were classified into the idiopathic pancreatitis group. Pancreatic carcinoma in the region of chronic pancreatitis was found in 13 patients (5.8%); stomach carcinoma was diagnosed in 3 patients with chronic pancreatitis, and oesophageal carcinoma in 1 patient of the total of patients monitored. Malignant pancreatic disease was diagnosed primarily in patients with alcoholic pancreatitis (4.5%). During the period of 14 years, 11 patients died, 8 of the deaths being associated with pancreatic carcinoma.
Both pancreatic and extrapancreatic carcinoma in gastrointestinal location is a serious complication of protracted chronic, non-hereditary pancreatitis. Systematic identification and treatment of patients with chronic pancreatitis is therefore necessary for timely diagnosis ofgastrointestinal and pancreatic malignancies.
胰腺癌是最常无法及时诊断的疾病之一,也没有办法有效地对胰腺癌患者进行筛查。因此,诊断“早期腺癌”的一个办法是识别并系统筛查有胰腺癌风险的患者。
我们在1992年至2005年期间对223例慢性胰腺炎患者进行了系统监测。在这14年期间,我们除了监测通过生化方法、内镜超声、CT和ERCP检查所测量的标准参数外,还监测了每年的吸烟量,并将男性每天饮酒超过80克且持续超过5年、女性每天饮酒超过50克且持续超过5年的慢性胰腺炎患者系统地归类为酒精性慢性胰腺炎,并根据TIGARO分类法对患者进行分类。
在接受检查的患者中,73.1%被证实为酒精性病因,21.5%的患者被诊断为慢性阻塞性胰腺炎,只有5.4%的患者被归类为特发性胰腺炎组。在慢性胰腺炎区域发现了13例胰腺癌患者(5.8%);在3例慢性胰腺炎患者中诊断出胃癌,在所有接受监测的患者中有1例被诊断出食管癌。恶性胰腺疾病主要在酒精性胰腺炎患者中被诊断出来(4.5%)。在14年期间,11例患者死亡,其中8例死亡与胰腺癌有关。
胃肠道部位的胰腺癌和胰腺外癌都是长期慢性非遗传性胰腺炎的严重并发症。因此,对慢性胰腺炎患者进行系统识别和治疗对于及时诊断胃肠道和胰腺恶性肿瘤是必要的。